大洋洲 · 区域市场 · Stockhead
Orthocell partner receives US FDA clearance for marine-derived bone graft
Perth-based Orthocell has finalised a strategic investment in Marine Biomedical in January 2026, increasing its equity interest to 12% for ... Read More The post Orthocell partner…
在 Stockhead 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (stockhead.com.au)




